Business
Press Release Nov 29 2022
Cipla Limited has informed the Exchange about press release dated 29-Nov-2022 titled Cipla announces launch of Leuprolide Acetate injection depot (22.5mg)
About this update from Cipla Ltd
Cipla Limited has informed the Exchange about press release dated 29-Nov-2022 titled Cipla announces launch of Leuprolide Acetate injection depot (22.5mg) View Attachment
More from Cipla Ltd
Cipla Announces Exclusive Partnership with Qilu Pharmaceutical for the Licensing and Supply of Biosimilar to Keytruda in the US
September 4, 2026
Cipla Announces Exclusive Partnership with Qilu Pharmaceutical for the Licensing and Supply of Biosimilar to Keytruda® (Pembrolizumab) in...
September 3, 2026